SCHEMBL24263202

SCHEMBL24263202

Cn1nc2c(cc1=O)CC(NC(=O)c1ccc(C(F)(F)F)cc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.47
CHRNB4 P30926 5/20 0.47
CHRNA3 P32297 5/20 0.47
CHRNA4 P43681 5/20 0.47
SLC6A5 Q9Y345 6/20 0.45
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PHGDH O43175 1/20 0.41
BRAF P15056 3/20 0.40
DRD4 P21917 2/20 0.40
DRD2 P14416 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
EGFR P00533 1/20 0.39
RAF1 P04049 1/20 0.39
LCK P06239 1/20 0.39
RET P07949 1/20 0.39
EPHA2 P29317 1/20 0.39
KDR P35968 1/20 0.39
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24263229 0.90 MEN1 (0.55) MEN1KMT2APHGDHBRAF
SCHEMBL24263133 0.89 NPC1 (0.45) MEN1KMT2AHDAC6
SCHEMBL24263083 0.88 NPC1 (0.46) MEN1KMT2A
SCHEMBL24263130 0.87 MEN1 (0.48) MEN1KMT2ADRD4DRD2
SCHEMBL24263096 0.87 ALDH1A1 (0.40) MEN1KMT2A
SCHEMBL24263099 0.87 HDAC8 (0.41) KMT2A
SCHEMBL24263210 0.87 MTNR1A (0.47) MEN1KMT2ADRD2
SCHEMBL24263225 0.83 SMN1; SMN2 (0.52) KMT2A
SCHEMBL24263219 0.82 DRD4 (0.46) DRD4DRD2
SCHEMBL24263232 0.80 MTNR1A (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040508-A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2022-02-24 WO disclosed